Bioavailability of paracetamol with/without caffeine in Egyptian patients with hepatitis C virus

Abstract

This study investigates the involvement of liver dysfunction in the modulation of paracetamol pharmacokinetic profile in genotype-4 HCV patients treated with either paracetamol alone (Para) or in combination with caffeine (Para-Caf). Twenty healthy volunteers and 20 Child-Pugh B HCV patients, each divided into two equal subgroups, were examined, whose liver… (More)
DOI: 10.1007/s00228-016-2025-1

Topics

5 Figures and Tables

Slides referencing similar topics